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INTRODUCTION  
Oestrus and mounting behaviors in 
female beef herds often lead to damage of carcass 
and reduction of feed intake. Gonadotropin 
releasing hormone (GnRH) vaccine suppresses 
gonadal functions in cattle, neutralize biological 
activity of endogenous GnRH by raising GnRH 
antibody. This method has been used as chemical 
castrations of young bulls and cows in several 
overseas countries. However, there have been no 
reports regarding effects of GnRH vaccine on 
gonadal functions of Japanese black fattening beef 
heifers. The present study was conducted to 
examine effects of Improvac®, a GnRH vaccine, on 
oestrus behavior, ovarian activity and growth in 
Japanese black fattening beef heifers. 
 
MATERIALS AND METHODS 
This study was conducted from March 
2017 to February 2018. Seven Japanese black 
fattening beef heifers at 10-11 months of age were 
used in this study. They were kept in Hyogo 
Prefecture College of Agriculture for fattening 
purpose and provided ad libitum hay and 
concentrate to meet or exceed the Japanese 
Feeding Standard recommendations for beef 
heifers. Four out of the seven heifers were treated 
with a GnRH vaccine, Improvac® (Zoetis Japan, 
Tokyo; 2 mL including 4 mg) subcutaneously at 10-
11 months of age (Week 0). The booster 
vaccinations were performed at Week 4, Week 20 
and Week 36. The other three heifers were not 
treated and used as a control. The following 
examinations were performed for 44 weeks from 
Week 0. Feed intake was examined at every feeding 
time (twice a day, morning and evening) by 
subtraction of remained amounts from provided 
amounts. Body weight was measured once a 
month. Standing and mounting behaviors were 
observed every day at twice a day. Palpation of 
ovaries and uterus per rectum was performed 
monthly. Blood samples was collected weekly from 
Week 0 to Week 8 and subsequently Weeks 12, 16, 
20, 22, 24, 28, 32, 36, 40 and 44. The blood was 
taken from jugular vein of beef heifers into 
heparinized tubes and immediately placed in ice 
before centrifuging (1,700 x g for 20 minutes at 
4˚C). The plasma was stored (-30˚C) until the assay. 
Plasma progesterone concentrations were assayed 
by EIA. Data were expressed as mean±SEM. We 
examined the effects of treatment and time, and 
interaction of both factors by conducting an 
analysis of variance (ANOVA) using the 
Generalized Linear Models procedure of SPSS ver. 
22 software (IBM, Somers, NY). The differences 
between GnRH vaccine treatment and control 
group were examined by conducting pairwise 
comparisons of the GLM procedure by the least 
significant difference (LSD) as a post hoc test. 
 
RESULTS AND DISCUSSIONS 
Occurrence of standing and mounting 
behaviors were more frequently in control group 
than GnRH vaccine treated group, especially after 
5-6 months after the second GnRH vaccine(the first 
booster injection; Table 1). In the control group, 
corpus luteum was palpated in the ovary until 
Week 36 after the start of the experiment (Table 2). 
However, the corpus luteum was palpated until 
Week 20 after the GnRH vaccine treatment and 
thereafter no corpus luteum was found in the 
ovary. In the control group, all three heifers 
showed cyclic increases of plasma progesterone 
concentrations over 0.5 ng/mL throughout the 
experimental period (Fig. 1). In the GnRH vaccine 
treated group, all four heifers showed cyclic 
increases of plasma progesterone concentrations 
over 0.5 ng/mL until Week 24, but after the time 
until Week 44 the progesterone concentrations 
were low less than 0.5 ng/mL. The effect of GnRH 
vaccine treatment was significant (P<0.0001) on 
weekly changes of plasma progesterone 
concentrations (Fig. 2). When the progesterone 
data were divided into “Before (Weeks 0-4 & 16-
20)” or “After (Weeks 5-12 & 22-44)” the GnRH 
vaccine treatment (Fig. 3), the progesterone 
concentrations were significantly lower 
(P<0.0001) in the GnRH vaccine treated group than 
in the control group in the “After” period. Body 
weight increased significantly (P<0.0001) during 
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the experimental period and there was no 
difference between the GnRH vaccine treated and 
control groups (Fig. 4). 
In this study we examined effects of 
GnRH vaccine, Improvac® on oestrous behaviors, 
ovarian cyclic activity and growth of Japanese black 
beef fattening heifers. GnRH vaccine compete with 
natural GnRH for binding to GnRH receptors, thus 
supressing or blocking GnRH action in the body[5]. 
GnRH is responsible for the release of LH and FSH 
from the pituitary, to maintain reproductice cycle 
of follicle in ovary[5]. Supressing GnRH will lead 
decreasing of ovarium activity. Progesteron is one 
of steroid hormone produced by corpus luteum in  
ovarium,  and can be used for indicator of ovarium 
activity. GnRH antagonist is not a hormone it was a 
vaccine, biohazard generally save, zero residu of 1 
day onset of action[4]. It can be used for alternative 
immunosterilisation in fattening program or 
population control[6]. 
GnRH antagonist Improvac® (Zoetis), 
was introduced to the market for 
immunocastration of male pig. A new vaccine 
Bopriva® designed specifically for cattle, is the 
only anti GnRH antagonist available in cattle on the 
market and has demonstrated good efficiency[3]. 
Improvac® consist of a synthetic GnRH analog 
coupled with diphtheria toxoid wich act as a larger 
immunogenic carrier protein for the analogue. 
Improvac® is also formulated with ionic 
polyshacaride adjuvant DEAE dextran, but  
Bopriva® couples DEAE dextran with another 
adjuvants that are capable of increasing the 
immune stimulation effect of a vaccine, while 
decreasing reactogeneticity at other adjuvant 
present. they do this by binding the other adjuvant 
thereby creating a new complex with altered 
reactogenicity [3].  
As the results, it is likely that treatment 
with GnRH vaccine reduced standing and mounting 
behaviors without effects on growth of heifers. The 
inhibitory effects on estrus behaviors of heifers 
were probably achieved by inhibition of ovarian 
cyclic activity because corpus luteum was not 
formed and plasma progesterone concentrations 
were lower than 0.5 ng/mL after Week 24 until the 
end of the experiment in the GnRH vaccine treated 
group. It is well known that the GnRH vaccine 
raises anti-GnRH antibody in the treated animals 
and neutralize endogenous GnRH, then suppresses 
LH secretion from anterior pituitary gland. 
However, in the GnRH vaccine treated group, 
progesterone concentrations increased Weeks 16 
and 20, indicating the inhibitory effect on ovary did 
not continue over 3 months after the booster 
injection at Week 4. The progesterone 
concentrations decreased after the third booster 
injection at Week 20 thereafter the concentrations 
were kept low levels until Week 36. These data 
suggest the inhibitory effects of GnRH vaccine on 
ovarian activity can continue only for 3 months. 
Thus 3 months intervals of the GnRH vaccine 
treatments may be recommended for complete 
suppression of ovarian activity and oestrus 
behaviors in the fattening beef heifers. 
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Fig. 1. Changes of plasma progesterone concentrations in 
individual Japanese Black fattening beef heifer between GnRH 
vaccine treatment (A-D) and untreated control (G-F) groups  
Weeks after the first GnRH vaccine
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CONCLUSIONS 
1. Treatment with GnRH vaccine, Improvac®, in 
Japanese black fattening beef heifers seems to 
reduce oestrus behaviors after 6 months of 
treatment without affecting body weight gain. 
2. Cyclic ovarian activity was suppressed for 3 
months after the booster injection of the GnRH 
vaccine. 
3. Further studies are required to determine 
optimal intervals of the GnRH vaccine 
treatments to suppress completely ovarian 
activity and oestrus behaviors in the fattening 
beef heifers. 
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Fig. 2. Effects of GnRH vaccine on changes of plasma 
progesterone concentrations in Japanese Black fattening 
beef heifers
Control
GnRH vaccine
Treatment P<0.0001
Time P<0.05
Interaction P<0.0001
Data were expressed as mean±SEM.
